2.02 The critical accounting estimates give no figures: no discount rate, no quantified change in the assumptions and no sensitivity, and the revenue estimate repeats the policy note
Company C · a US-listed specialty healthcare products company · Compliance or disclosure gap
In brief
Management's discussion and analysis (MD&A) names two critical accounting estimates. For the contingent royalty obligation to the Company founders, a liability of [n] whose revaluation moved the operating result by a [n] gain in 2025 after a [n] loss in 2024, it lists the inputs in words only: no discount rate, no statement of how the assumptions changed and no sensitivity. The revenue estimate restates the five-step model and the loyalty-reward wording of the revenue note. Item 303(b)(3) requires quantitative information, including change over the period and sensitivity, where material and reasonably available.
The evidence, as filed
Screenshot withheld to protect the company’s identity. Even with names, figures and dates boxed out, the wording on these pages could be searched back to the filer. Pages relied on: Form 10-K 2024 (prior year), page 59; Form 10-K 2025, page 56; Form 10-K 2025, page 57.
What the filing shows, and what the rule requires
| What the filing shows | What the rule requires |
|---|---|
Contingent royalty estimate: inputs listed in words; no discount rate, no change analysis, no sensitivity, although the swing between 2024 and 2025 was [n] and the fair value note gives rates of [n]% and [n]%. Revenue estimate: the five-step model and the Reward measurement sentence that the revenue note already gives. The 2024 Form 10-K had the same text. | For each critical accounting estimate: why it is uncertain, how much the key assumptions changed in the year (discount rate [n]% to [n]%; projected Product 1 revenue), the effect of a reasonably possible change in each assumption on the [n] liability, and for the loyalty Reward the liability, redemption rate and the effect of a change in it, without repeating the policy note. |
| What we checked. Both critical accounting estimates in Form 10-K 2025 and Form 10-K 2024 (prior year); the fair value note; the auditor's critical audit matter; whole-document search for sensitivity wording | |
The rule
Regulation S-K Item 303(b)(3)
Provide qualitative and quantitative information necessary to understand the estimation uncertainty and the impact the critical accounting estimate has had or is reasonably likely to have on financial condition or results of operations to the extent the information is material and reasonably available. This information should include why each critical accounting estimate is subject to uncertainty and, to the extent the information is material and reasonably available, how much each estimate and/or assumption has changed over a relevant period, and the sensitivity of the reported amount to the methods, assumptions and estimates underlying its calculation.
Version: Text in force at the date of this review · Source: Regulation S-K, 17 CFR 229.303(b)(3), as amended by Release 33-10890
Regulation S-K Item 303, Instruction 3 to paragraph (b)
For critical accounting estimates, this disclosure must supplement, but not duplicate, the description of accounting policies or other disclosures in the notes to the financial statements.
Version: Text in force at the date of this review · Source: Regulation S-K, 17 CFR 229.303, Instructions to paragraph (b), as amended by Release 33-10890
Why it applies here. Quantitative change and sensitivity information wholly absent in both years
Why it matters
Critical accounting estimates are a standing staff comment theme; a reader cannot judge how far the [n] liability, and the operating result it drives, could move.
Exposure
A staff comment letter asking for expanded critical accounting estimates and a future-filings undertaking; no penalty is fixed for this omission.
Our workings
the critical accounting estimates section covers revenue recognition and the contingent royalty obligation. The royalty paragraph lists projected net revenues, the discount rate and timing of payments as inputs and says a change in the discount rate could materially affect fair value, but gives no figure; the results discussion names the same drivers of the revaluation in words only. The fair value note states discount rates of [n]% (2025) and [n]% (2024). The auditor's critical audit matter is this estimate, singling out the projected US net revenues of Product 1, and the auditor performed sensitivity analyses. The revenue paragraph repeats the five-step model and, almost word for word, the note's sentence on measuring the Reward.
the liability is [n] + [n] = [n] at [date]; the revaluation swung from a [n] loss to a [n] gain, [n] in all, equal to 26.60% of the 2025 pre-tax loss; the 2025 gain alone is 12.52% of it.
an estimate of this size and volatility is material, and the inputs (rates, revenue projections, the auditor's sensitivity runs) are plainly available, so the 'material and reasonably available' condition does not excuse the omission. Instruction 3 to paragraph (b) forbids the critical accounting estimates from duplicating the policy note, which the revenue paragraph does.
| Item | 2025 | 2024 | Computation | Result |
|---|---|---|---|---|
| Contingent royalty obligation (balance sheet, p.62) | [n] + [n] | [n] + [n] | [n] + [n] = [n]; [n] + [n] = [n] | [n] / [n] |
| Revaluation in operating expenses | ([n]) gain | [n] loss | [n] + [n] | [n] swing |
| Swing as share of 2025 pre-tax loss | [n] / [n] | 26.60% | ||
| 2025 gain as share of 2025 pre-tax loss | [n] / [n] | 12.52% | ||
| Discount rate (fair value note, p.79) | [n]% | [n]% | [n]% - [n]% | 1 point; not in MD&A |
| Requirement | What the critical accounting estimate says | Status | Page |
|---|---|---|---|
| Why the estimate is uncertain | Level 3 inputs: projected net revenues, discount rate, timing | Given | p.57 |
| How much the estimate or its assumptions changed over a relevant period | Nothing; the [n]% to [n]% rate change is only in the note | Absent | p.57; note p.79 |
| Sensitivity of the reported amount to the assumptions | Direction only (significantly lower or higher) | Absent | p.57 |
| Supplement, not duplicate, the policy note | Revenue paragraph repeats the five-step model and the Reward sentence of the note | Duplicated | p.56-57, [n] |
| Same in the prior-year Form 10-K | Same qualitative text | Absent | Form 10-K 2024 (prior year) p.59 |
Management’s best defense, and our reply
The company can argue that quantitative sensitivity is due only to the extent it is material and reasonably available, that the fair value note already gives the [n]% and [n]% discount rates and the Level 3 roll-forward, and that repeating them in MD&A would offend the instruction against duplication. It may add that the obligation ends in mid-2029, so its sensitivity is shrinking. However, the note gives the rates but no sensitivity and no reason for a [n] swing between a loss and a gain; the auditor's own procedures included sensitivity analyses, so the figures are reasonably available, and an item equal to 12.52% of the pre-tax loss is material. The duplication argument cuts the other way: the revenue paragraph is the part that duplicates the note.
The fix
- Add to the royalty estimate: 'We used a discount rate of [n]% (2024: [n]%). A one-point increase (decrease) in the discount rate would decrease (increase) the liability by $[x] million; a 10% decrease in projected Product 1 net revenues would decrease it by $[y] million. The 2025 gain reflected [the drivers].' Replace the revenue five-step text with the Reward liability, the redemption-rate assumption and its sensitivity.
Evidence relied on
| # | What it shows | Type | Where |
|---|---|---|---|
| 1 | The 2025 critical accounting estimate lists the inputs in words only | Document | Form 10-K 2025, page 57 |
| 2 | The revenue estimate restates the five-step model | Document | Form 10-K 2025, page 56 |
| 3 | Reward measurement sentence in the critical accounting estimate | Document | Form 10-K 2025, page 57 |
| 4 | The same sentence in the revenue note | Document | Form 10-K 2025, page 74 |
| 5 | Discount rates at both year ends appear only in the fair value note | Document | Form 10-K 2025, page 79 |
| 6 | The auditor's critical audit matter is this estimate and its revenue projection | Document | Form 10-K 2025, page 61 |
| 7 | Sensitivity information exists and was run by the auditor | Document | Form 10-K 2025, page 61 |
| 8 | Revaluation gain in 2025 and loss in 2024 in operating expenses | Document | Form 10-K 2025, page 49 |
| 9 | Current portion of the liability | Document | Form 10-K 2025, page 62 |
| 10 | Non-current portion of the liability | Document | Form 10-K 2025, page 62 |
| 11 | The 2024 Form 10-K gave the same direction-only wording | Document | Form 10-K 2024 (prior year), page 59 |
Absence check
- Document
- Form 10-K 2025
- Where it would appear
- Contingent Royalty Obligation to the Company founders
- What is missing
- the discount rate and revenue assumptions used, how they changed in 2025, and the sensitivity of the [n] liability to them
- Pages looked at
- p.48-57 (MD&A), [n] (critical audit matter), [n] (fair value note)
- Result
- the stem 'sensitiv' hits p.1, [n] and [n] ('sensitive' information in the data-protection risk factors, not this estimate) and p.61 (the auditor's procedures, not management's disclosure); '[n]%' hits only p.79, the fair value note, which gives the rate but no sensitivity; 'hypothetical' and 'basis point' do not hit
Prepared by Pramanex from the company’s public SEC filings, without the company’s involvement, to show how a 10-K Pre-filing Check reads. The company is not named, and nothing on this page is a statement about any identifiable company. Observations are not an audit, review or other attestation or assurance engagement, and not legal advice. An SEC-style question is a question, not a conclusion.
Want this on your own 10-K, before you file?
Start with three free findings on your latest 10-K, or book a fixed-price 10-K Pre-filing Check.
Your next 10-K will be in draft before the audit is done.
Have it read before you file.
Start with three free findings on your latest 10-K, or book a fixed-price 10-K check. Drafts only under NDA, inside your insider trading policy.